| April Nicole Kolb, DO | |
|
842 Ne Alices Rd, Waukee, IA 50263-8857 | |
| (515) 875-9610 | |
| (515) 875-9611 |
| Full Name | April Nicole Kolb |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 842 Ne Alices Rd, Waukee, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811378086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04890 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Iowa Clinic Pc | 4082513742 | 273 |
News Archive
Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031'') and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.
Middle-aged couch potatoes may reduce or reverse the risk of heart failure associated with years of sitting if they participate in two years of regular aerobic exercise training, according to a new study in the American Heart Association's journal Circulation.
For National Neuropathy Week, May 17-21, The Neuropathy Association will join with the Empire State Building to raise neuropathy awareness, recognize National Neuropathy Week, and commemorate the Association's 15th Anniversary.
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."
About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly replicating cancer cells that generate the immature blood cells characteristic of leukemia and are resistant to typical cancer treatments.
› Verified 9 days ago
| Entity Name | The Iowa Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346233178 PECOS PAC ID: 4082513742 Enrollment ID: O20040102000222 |
News Archive
Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031'') and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.
Middle-aged couch potatoes may reduce or reverse the risk of heart failure associated with years of sitting if they participate in two years of regular aerobic exercise training, according to a new study in the American Heart Association's journal Circulation.
For National Neuropathy Week, May 17-21, The Neuropathy Association will join with the Empire State Building to raise neuropathy awareness, recognize National Neuropathy Week, and commemorate the Association's 15th Anniversary.
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."
About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly replicating cancer cells that generate the immature blood cells characteristic of leukemia and are resistant to typical cancer treatments.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| April Nicole Kolb, DO Po Box 424, Des Moines, IA 50302-0424 Ph: (515) 875-9255 | April Nicole Kolb, DO 842 Ne Alices Rd, Waukee, IA 50263-8857 Ph: (515) 875-9610 |
News Archive
Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031'') and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.
Middle-aged couch potatoes may reduce or reverse the risk of heart failure associated with years of sitting if they participate in two years of regular aerobic exercise training, according to a new study in the American Heart Association's journal Circulation.
For National Neuropathy Week, May 17-21, The Neuropathy Association will join with the Empire State Building to raise neuropathy awareness, recognize National Neuropathy Week, and commemorate the Association's 15th Anniversary.
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."
About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly replicating cancer cells that generate the immature blood cells characteristic of leukemia and are resistant to typical cancer treatments.
› Verified 9 days ago
Dr. William H Schupp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 842 Ne Alices Rd, Waukee, IA 50263 Phone: 515-875-9610 Fax: 515-875-9611 | |
Johanna Engel-brower, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 E Hickman Rd, Waukee, IA 50263 Phone: 515-987-3447 Fax: 515-987-6957 | |
Dr. William B Goble, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Se Tallgrass Lane Ste 150, Waukee, IA 50263 Phone: 515-875-8070 Fax: 515-875-8071 | |
Brianne Nicole Day, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 W Hickman Road, Waukee, IA 50263 Phone: 515-643-7000 Fax: 515-643-7001 | |
Dr. Taylor Jo Johnson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1025 Se Tallgrass Lane Ste 250, Waukee, IA 50263 Phone: 515-875-8300 Fax: 515-875-8201 | |
Dr. Christine Schaplowsky Davis, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Bel Aire Dr, Waukee, IA 50263 Phone: 916-390-4195 | |
Imad F Francis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Se Tallgrass Lane Ste 150, Waukee, IA 50263 Phone: 515-875-8070 Fax: 515-875-8071 |